Business Context and Reporting Period
Cocrystal Pharma, Inc. (COCP), a Delaware corporation, filed this Form 8-K on May 11, 2020. The filing serves as a Regulation FD disclosure to make an updated corporate presentation available to the public.
Financial Metrics
This filing does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity within this document.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely announces the release of a corporate presentation.
Guidance, Outlook, and Risks
The filing references an updated corporate presentation (Exhibit 99.1) which may contain management commentary or outlook, but the text of the presentation is not included in this report. The filing explicitly states that the information in Item 7.01 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings.
Key Facts for Investor Verification
- Verify the content of the "Cocrystal Pharma, Inc. Corporate Presentation, dated May 2020" (Exhibit 99.1) for any new strategic or financial updates.
- Confirm that the presentation is accessible on the company website at www.cocrystalpharma.com.
- Note that the presentation materials are not legally "filed" with the SEC and do not carry the same liability protections as standard SEC filings.